Abiopharma

New Form 8-K - ARDELYX, INC. Filed: 2025-07-03 AccNo: 0001628280-25-034132 Size: 793 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits